Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1529516
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1529516
Single Cell Analysis Market Size, Share & Trends By Product (Consumables, Instruments), Cell Type, Technique, Application (Research, Medical ) - Global Forecast to 2029
PUBLISHED:
PAGES: 484 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The single-cell analysis market is projected to reach USD 6.9 billion by 2029 from an estimated USD 3.7 billion in 2024, at a CAGR of 13.6% during the forecast period from 2024 to 2029. The growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in stem cell research and technological advancements in single-cell analysis products are expected to contribute to the growth of single-cell analysis market. Also, growing incidences of cancer is promoting the need of advanced therapies resulting to boost the growth of single-cell analysis market. Moreover, rising adoption of advanced single-cell sequencing technique is expected to propel the market growth in coming years.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Billion) |
| Segments | Product, Cell Type, Technique, Application, and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
"The research application segment accounted for the largest share of by application segment in 2023."
Based on application, single-cell analysis market is segmented into research application and medical application. Research application further categories into cancer research, immunology research, neurology research, stem cell research, and other research applications. Similarly, medical research is divided into non invasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection. In 2023, the research application segment accounted for the largest share of the global single-cell analysis market by application. Increasing prevalence of cancer is driving the need of advanced thearpies resulting to promote segment's growth in the single-cell analysis market. Additionally, growth in stem cell research is anticipated to promote the segment's growth in single-cell analysis market.
"The flow cytometry segment accounted for the major share of by technology segment in 2023."
Based on technology, single-cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2023, the flow cytometry segment accounted for the major share of the global single-cell analysis market by technology. The growth of the flow cytometry segment is primarily attributed to the wide usage of flow cytometry in single-cell analysis application due to its ability to perform multiple measurements within heterogeneous mixture. Additionally, growing adoption of advanced technologies for cell identification and cell characterization is anticipated to boost the segment growth in single-cell analysis market.
"The US has continued to dominate the single-cell analysis market in 2023."
Based on the region, the single-cell analysis market is segmented into six major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, US dominated the single-cell analysis market in North America. The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The US also has a strong healthcare infrastructure, which drives research and development in the life sciences sector. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, growing focus on development of personalized medicine due to growing incidences of cancer is also driving the growth of the single-cell analysis market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Merck KGaA (Germany)
- BD (US)
- Agilent Technologies, Inc. (US)
- QIAGEN (Netherlands)
- 10x Genomics (US)
- Illumina, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- DiaSorin S.p.A. (Italy)
- Standard BioTools (US)
- Tecan Trading AG (Switzerland)
- Sartorius AG (Germany)
- Corning Incorporated (US)
- Cytek Biosciences (US)
- Takara Bio Inc. (Japan)
- BIOMERIEUX (France)
- Revvity (US)
- Bio-Techne (US)
- PacBio (US)
- Bruker (US)
- Promega Corporation (US)
- Oxford Nanopore Technologies plc. (UK)
- The Menarini Group (Italy)
- Singleron Biotechnologies (Germany)
- BICO (Sweden)
- Fluent BioSciences (US)
- RareCyte, Inc. (US)
- Cell Microsystems (US)
- NanoCellect Biomedical (US)
- Sphere Fluidics (UK)
- On-chip Biotechnologies Co., Ltd. Corporation (Japan)
- Apogee Flow Systems Ltd. (UK)Merck KGaA (Germany)
Research Coverage:
This research report categorizes the single-cell analysis market by product (consumables (reagents, assay kits (immuno assays and cell based assays), beads, microplates, and other consumables) and instruments(PCR instruments, NGS systems, flow cytometers, spectrophotometers, cell counters, microscopes, HCS systems, microarrays, and other instruments)), cell type (human cells, animal cells, and microbial cells), technique (flow cytometry, next-generation sequencing, microscopy, polymerase chain reaction, mass spectrometry, and other techniques), application (research application (cancer research, immunology research, neurology research, stem cell research, other research applications) and medical application (non invasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection), end user (academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-cell analysis market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-cell analysis market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (technological advancements in single-cell analysis products, surge in cases of cancer, and increasing R&D in pharmaceutical & biotechnology industries for complex diseases), restraints (high cost of single-cell analysis products), opportunities (integration of microfluidics in single-cell analysis), and Challenges (standardization of protocols and data integration & quality control for developing cell therapies) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the single-cell analysis market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market
- Competitive Assessment: . Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), BIOMERIEUX (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies plc. (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Sphere Fluidics (UK), On-chip Biotechnologies Co., Ltd. Corporation (Japan), and Apogee Flow Systems Ltd. (UK), among others in the market.
Product Code: BT 4224
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 YEARS CONSIDERED
- 1.3.3 INCLUSIONS AND EXCLUSIONS
- 1.4 CURRENCY CONSIDERED
- 1.5 UNIT CONSIDERED
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
- 2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION, 2023
- 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
- 2.2.3 TOP-DOWN APPROACH
- 2.3 MARKET GROWTH RATE PROJECTIONS
- 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RISK ANALYSIS
- 2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET
- 4.2 SINGLE-CELL ANALYSIS MARKET IN NORTH AMERICA, BY CELL TYPE AND COUNTRY
- 4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT
- 4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER
- 4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Technological advancements in single-cell analysis products
- 5.2.1.2 Rising prevalence of cancer
- 5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries
- 5.2.1.4 Growth in stem cell research
- 5.2.1.5 Growing focus on personalized medicine
- 5.2.2 RESTRAINTS
- 5.2.2.1 High cost of single-cell analysis products
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 High growth potential of single-cell sequencing
- 5.2.3.2 Integration of microfluidics in single-cell analysis
- 5.2.3.3 Rising potential in emerging Asian markets
- 5.2.4 CHALLENGES
- 5.2.4.1 Lack of standardization in protocols and quality control procedures
- 5.2.4.2 Technical limitations of single-cell analysis
- 5.2.4.3 Mounting ethical and privacy concerns
- 5.2.1 DRIVERS
- 5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
- 5.3.1.1 Flow cytometry
- 5.3.1.2 Next-generation sequencing
- 5.3.1.3 Polymerase chain reaction
- 5.3.1.4 Microscopy
- 5.3.1.5 Mass spectrometry
- 5.3.2 COMPLEMENTARY TECHNOLOGIES
- 5.3.2.1 Bioinformatics tools and computational analysis
- 5.3.2.2 Multi-omics integration
- 5.3.3 ADJACENT TECHNOLOGIES
- 5.3.3.1 Nanotechnology
- 5.3.3.2 Artificial intelligence and machine learning
- 5.3.1 KEY TECHNOLOGIES
- 5.4 SUPPLY CHAIN ANALYSIS
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.9 PATENT ANALYSIS
- 5.9.1 METHODOLOGY
- 5.9.2 PATENTS APPLIED AND GRANTED, 2014-2024
- 5.10 KEY CONFERENCES AND EVENTS, 2024-2025
- 5.11 REGULATORY LANDSCAPE
- 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11.2 REGULATIONS
- 5.12 PORTER'S FIVE FORCES ANALYSIS
- 5.12.1 THREAT OF NEW ENTRANTS
- 5.12.2 THREAT OF SUBSTITUTES
- 5.12.3 BARGAINING POWER OF SUPPLIERS
- 5.12.4 BARGAINING POWER OF BUYERS
- 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
- 5.13.3 BUYING CRITERIA
- 5.14 INVESTMENT AND FUNDING SCENARIO
- 5.15 TRADE ANALYSIS
- 5.15.1 IMPORT DATA (HS CODE 9027)
- 5.15.2 EXPORT DATA (HS CODE 9027)
- 5.16 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET
6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 CONSUMABLES
- 6.2.1 BEADS
- 6.2.1.1 Increasing use in research and genetic exploration to drive market
- 6.2.2 MICROPLATES
- 6.2.2.1 Rising frequency of product launches to boost market
- 6.2.3 REAGENTS
- 6.2.3.1 Advancements in single-cell genomics to increase demand
- 6.2.4 ASSAY KITS
- 6.2.4.1 Immunoassays
- 6.2.4.1.1 Growth in geriatric population to fuel demand
- 6.2.4.2 Cell-based assays
- 6.2.4.2.1 Increasing use in pharma and biopharma companies to drive market
- 6.2.4.1 Immunoassays
- 6.2.5 OTHER CONSUMABLES
- 6.2.1 BEADS
- 6.3 INSTRUMENTS
- 6.3.1 FLOW CYTOMETERS
- 6.3.1.1 Technological advancements to drive demand
- 6.3.2 NGS SYSTEMS
- 6.3.2.1 Increased affordability to support segment growth
- 6.3.3 PCR INSTRUMENTS
- 6.3.3.1 Rising use for DNA and mRNA amplification to boost market
- 6.3.4 SPECTROPHOTOMETERS
- 6.3.4.1 Technological advancements to boost market
- 6.3.5 CELL COUNTERS
- 6.3.5.1 Rising demand for automated cell counters to fuel market
- 6.3.6 MICROSCOPES
- 6.3.6.1 Increasing use in cell-based research to drive market
- 6.3.7 HCS SYSTEMS
- 6.3.7.1 Growing need for multi-parametric cell analysis to drive adoption
- 6.3.8 MICROARRAYS
- 6.3.8.1 Increasing development of targeted therapies to support market
- 6.3.9 OTHER INSTRUMENTS
- 6.3.1 FLOW CYTOMETERS
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE
- 7.1 INTRODUCTION
- 7.2 HUMAN CELLS
- 7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
- 7.3 ANIMAL CELLS
- 7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
- 7.4 MICROBIAL CELLS
- 7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE
- 8.1 INTRODUCTION
- 8.2 FLOW CYTOMETRY
- 8.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
- 8.3 NEXT-GENERATION SEQUENCING
- 8.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET
- 8.4 POLYMERASE CHAIN REACTION
- 8.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET
- 8.5 MICROSCOPY
- 8.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET
- 8.6 MASS SPECTROMETRY
- 8.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
- 8.7 OTHER TECHNIQUES
9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION
- 9.1 INTRODUCTION
- 9.2 RESEARCH APPLICATIONS
- 9.2.1 CANCER RESEARCH
- 9.2.1.1 Rising prevalence of cancer to drive market
- 9.2.2 IMMUNOLOGY RESEARCH
- 9.2.2.1 High incidence of immunological disorders to propel market
- 9.2.3 NEUROLOGY RESEARCH
- 9.2.3.1 Increasing incidence of neurological disorders to boost market
- 9.2.4 STEM CELL RESEARCH
- 9.2.4.1 Rising investments in stem cell research to drive market
- 9.2.5 OTHER RESEARCH APPLICATIONS
- 9.2.1 CANCER RESEARCH
- 9.3 MEDICAL APPLICATIONS
- 9.3.1 NON-INVASIVE PRENATAL DIAGNOSIS
- 9.3.1.1 Increasing prevalence of genetic diseases to drive demand
- 9.3.2 IN VITRO FERTILIZATION
- 9.3.2.1 Growing demand for IVF procedures to support market
- 9.3.3 CIRCULATING TUMOR CELL DETECTION
- 9.3.3.1 Rising prevalence of cancer to contribute to segment growth
- 9.3.1 NON-INVASIVE PRENATAL DIAGNOSIS
10 SINGLE-CELL ANALYSIS MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 ACADEMIC & RESEARCH LABORATORIES
- 10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
- 10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
- 10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET
- 10.4 HOSPITALS & DIAGNOSTIC LABORATORIES
- 10.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND
- 10.5 CELL BANKS & IVF CENTERS
- 10.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET
11 SINGLE-CELL ANALYSIS MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.1.1 Increasing R&D investments and funding to drive market
- 11.2.2 CANADA
- 11.2.2.1 High prevalence of hemophilia to propel market
- 11.2.1 US
- 11.3 EUROPE
- 11.3.1 GERMANY
- 11.3.1.1 Growing awareness of advanced cell therapies to support market
- 11.3.2 UK
- 11.3.2.1 Growing adoption of single-cell analysis products to drive demand
- 11.3.3 FRANCE
- 11.3.3.1 Growing government funding for R&D to propel market
- 11.3.4 ITALY
- 11.3.4.1 Focus on cell biology research to drive market
- 11.3.5 SPAIN
- 11.3.5.1 Increasing number of biotechnology companies to drive demand
- 11.3.6 REST OF EUROPE
- 11.3.1 GERMANY
- 11.4 ASIA PACIFIC
- 11.4.1 CHINA
- 11.4.1.1 Increasing R&D expenditure to support market
- 11.4.2 JAPAN
- 11.4.2.1 Increasing geriatric population to fuel demand
- 11.4.3 INDIA
- 11.4.3.1 Growing focus on development of cell-based therapies to boost market
- 11.4.4 SOUTH KOREA
- 11.4.4.1 Increasing number of strategic alliances to boost market
- 11.4.5 AUSTRALIA
- 11.4.5.1 Rising number of life science companies to boost demand
- 11.4.6 REST OF ASIA PACIFIC
- 11.4.1 CHINA
- 11.5 LATIN AMERICA
- 11.5.1 BRAZIL
- 11.5.1.1 Rising focus on biotechnology industry to bolster market
- 11.5.2 MEXICO
- 11.5.2.1 Government support for biopharmaceutical production to drive market
- 11.5.3 REST OF LATIN AMERICA
- 11.5.1 BRAZIL
- 11.6 MIDDLE EAST
- 11.6.1 GCC
- 11.6.1.1 Focus on advancement of local biopharmaceutical industry to drive market
- 11.6.1.2 Saudi Arabia
- 11.6.1.2.1 Increasing healthcare expenditure to drive market
- 11.6.1.3 United Arab Emirates
- 11.6.1.3.1 Advancements in biopharmaceutical sector to drive demand
- 11.6.1.4 Rest of GCC
- 11.6.2 REST OF MIDDLE EAST
- 11.6.1 GCC
- 11.7 AFRICA
- 11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
12 COMPETITIVE LANDSCAPE
- 12.1 OVERVIEW
- 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023
- 12.3 REVENUE ANALYSIS, 2021-2023
- 12.4 MARKET SHARE ANALYSIS, 2023
- 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 12.5.5.1 Company footprint
- 12.5.5.2 Product footprint
- 12.5.5.3 Region footprint
- 12.5.5.4 Technique footprint
- 12.5.5.5 Application footprint
- 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 12.6.5.1 Detailed list of key startups/SMEs
- 12.6.5.2 Competitive benchmarking of key startups/SMEs
- 12.7 COMPANY VALUATION AND FINANCIAL METRICS
- 12.8 BRAND/PRODUCT COMPARISON
- 12.9 COMPETITIVE SCENARIO AND TRENDS
- 12.9.1 PRODUCT LAUNCHES & APPROVALS
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS
13 COMPANY PROFILES
- 13.1 INTRODUCTION
- 13.2 KEY PLAYERS
- 13.2.1 BD
- 13.2.1.1 Business overview
- 13.2.1.2 Products offered
- 13.2.1.3 Recent developments
- 13.2.1.3.1 Product launches & approvals
- 13.2.1.3.2 Deals
- 13.2.1.4 MnM view
- 13.2.1.4.1 Key strengths
- 13.2.1.4.2 Strategic choices
- 13.2.1.4.3 Weaknesses and competitive threats
- 13.2.2 THERMO FISHER SCIENTIFIC INC.
- 13.2.2.1 Business overview
- 13.2.2.2 Products offered
- 13.2.2.3 Recent developments
- 13.2.2.3.1 Product launches & approvals
- 13.2.2.3.2 Deals
- 13.2.2.4 MnM view
- 13.2.2.4.1 Key strengths
- 13.2.2.4.2 Strategic choices
- 13.2.2.4.3 Weaknesses and competitive threats
- 13.2.3 DANAHER CORPORATION
- 13.2.3.1 Business overview
- 13.2.3.2 Products offered
- 13.2.3.3 Recent developments
- 13.2.3.3.1 Deals
- 13.2.3.4 MnM view
- 13.2.3.4.1 Key strengths
- 13.2.3.4.2 Strategic choices
- 13.2.3.4.3 Weaknesses and competitive threats
- 13.2.4 10X GENOMICS
- 13.2.4.1 Business overview
- 13.2.4.2 Products offered
- 13.2.4.3 Recent developments
- 13.2.4.3.1 Product launches & approvals
- 13.2.4.3.2 Deals
- 13.2.5 MERCK KGAA
- 13.2.5.1 Business overview
- 13.2.5.2 Products offered
- 13.2.5.3 Recent developments
- 13.2.5.3.1 Deals
- 13.2.6 AGILENT TECHNOLOGIES, INC.
- 13.2.6.1 Business overview
- 13.2.6.2 Products offered
- 13.2.6.3 Recent developments
- 13.2.6.3.1 Product launches & approvals
- 13.2.6.3.2 Deals
- 13.2.7 QIAGEN
- 13.2.7.1 Business overview
- 13.2.7.2 Products offered
- 13.2.7.3 Recent developments
- 13.2.7.3.1 Deals
- 13.2.8 ILLUMINA, INC.
- 13.2.8.1 Business overview
- 13.2.8.2 Products offered
- 13.2.8.3 Recent developments
- 13.2.8.3.1 Product launches & approvals
- 13.2.8.3.2 Deals
- 13.2.9 BIO-RAD LABORATORIES, INC.
- 13.2.9.1 Business overview
- 13.2.9.2 Products offered
- 13.2.9.3 Recent developments
- 13.2.9.3.1 Product launches & approvals
- 13.2.10 DIASORIN S.P.A.
- 13.2.10.1 Business overview
- 13.2.10.2 Products offered
- 13.2.10.3 Recent developments
- 13.2.10.3.1 Deals
- 13.2.11 STANDARD BIOTOOLS
- 13.2.11.1 Business overview
- 13.2.11.2 Product offered
- 13.2.11.3 Recent developments
- 13.2.11.3.1 Product launches & approvals
- 13.2.11.3.2 Deals
- 13.2.12 TECAN TRADING AG
- 13.2.12.1 Business overview
- 13.2.12.2 Products offered
- 13.2.13 SARTORIUS AG
- 13.2.13.1 Business overview
- 13.2.13.2 Products offered
- 13.2.13.3 Recent developments
- 13.2.13.3.1 Expansions
- 13.2.14 CORNING INCORPORATED
- 13.2.14.1 Business overview
- 13.2.14.2 Products offered
- 13.2.15 CYTEK BIOSCIENCES
- 13.2.15.1 Business overview
- 13.2.15.2 Products offered
- 13.2.15.3 Recent developments
- 13.2.15.3.1 Expansions
- 13.2.16 TAKARA BIO INC.
- 13.2.16.1 Business overview
- 13.2.16.2 Products offered
- 13.2.17 BIOMERIEUX
- 13.2.17.1 Business overview
- 13.2.17.2 Products offered
- 13.2.17.3 Recent developments
- 13.2.17.3.1 Deals
- 13.2.18 REVVITY
- 13.2.18.1 Business overview
- 13.2.18.2 Products offered
- 13.2.18.3 Recent developments
- 13.2.18.3.1 Deals
- 13.2.19 BIO-TECHNE
- 13.2.19.1 Business overview
- 13.2.19.2 Products offered
- 13.2.19.3 Recent developments
- 13.2.19.3.1 Deals
- 13.2.20 PACBIO
- 13.2.20.1 Business overview
- 13.2.20.2 Products offered
- 13.2.20.3 Recent developments
- 13.2.20.3.1 Product launches & approvals
- 13.2.21 BRUKER
- 13.2.21.1 Business overview
- 13.2.21.2 Products offered
- 13.2.21.3 Recent developments
- 13.2.21.3.1 Product launches & approvals
- 13.2.22 PROMEGA CORPORATION
- 13.2.22.1 Business overview
- 13.2.22.2 Products offered
- 13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC
- 13.2.23.1 Business overview
- 13.2.23.2 Products offered
- 13.2.1 BD
- 13.3 OTHER PLAYERS
- 13.3.1 SINGLERON BIOTECHNOLOGIES
- 13.3.2 CELL MICROSYSTEMS
- 13.3.3 NANOCELLECT BIOMEDICAL
- 13.3.4 RARECYTE, INC.
- 13.3.5 BICO
- 13.3.6 MENARINI GROUP
14 DISCUSSION GUIDE
- 14.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 14.2 CUSTOMIZATION OPTIONS
- 14.3 RELATED REPORTS
- 14.4 AUTHOR DETAILS
Product Code: BT 4224
List of Tables
- TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
- TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES
- TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
- TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
- TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019-2025
- TABLE 7 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS
- TABLE 8 TYPES OF BIOINFORMATICS TOOLS
- TABLE 9 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021-2023
- TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
- TABLE 11 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS
- TABLE 12 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS
- TABLE 13 SINGLE-CELL ANALYSIS MARKET: END USERS
- TABLE 14 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES
- TABLE 15 PATENTS FILED, 2014-2024
- TABLE 16 INNOVATIONS AND PATENT REGISTRATIONS, 2023-2024
- TABLE 17 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
- TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES
- TABLE 23 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 24 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER
- TABLE 25 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019-2023 (USD THOUSAND)
- TABLE 26 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019-2023 (TONS)
- TABLE 27 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019-2023 (USD THOUSAND)
- TABLE 28 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019-2023 (TONS)
- TABLE 29 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
- TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 32 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 33 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 34 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 35 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 36 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 37 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 38 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 39 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 40 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 41 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 42 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 43 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 44 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 45 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 46 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 47 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 48 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 49 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 50 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 51 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 53 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 54 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 55 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 56 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 57 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 58 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 60 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 61 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 62 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 63 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 64 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 65 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 66 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 67 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 68 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 69 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 70 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 71 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 72 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 73 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 74 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 75 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 76 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 77 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 78 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 79 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 80 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 82 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 83 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 84 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 85 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 86 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 87 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 90 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 91 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 92 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 93 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 94 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 95 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 96 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 97 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 98 EUROPE: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 99 ASIA PACIFIC: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 100 LATIN AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 101 MIDDLE EAST: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 102 GCC: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 103 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 104 NORTH AMERICA: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 105 EUROPE: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 106 ASIA PACIFIC: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 107 LATIN AMERICA: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 108 MIDDLE EAST: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 109 GCC: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 110 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 112 EUROPE: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 113 ASIA PACIFIC: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 114 LATIN AMERICA: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 115 MIDDLE EAST: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 116 GCC: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 117 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 118 NORTH AMERICA: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 119 EUROPE: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 120 ASIA PACIFIC: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 121 LATIN AMERICA: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 122 MIDDLE EAST: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 123 GCC: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 124 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 125 NORTH AMERICA: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 126 EUROPE: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 127 ASIA PACIFIC: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 128 LATIN AMERICA: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 129 MIDDLE EAST: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 130 GCC: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 131 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 132 NORTH AMERICA: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 133 EUROPE: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 134 ASIA PACIFIC: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 135 LATIN AMERICA: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 136 MIDDLE EAST: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 137 GCC: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 138 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 139 NORTH AMERICA: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 140 EUROPE: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 141 ASIA PACIFIC: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 142 LATIN AMERICA: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 143 MIDDLE EAST: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 144 GCC: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 145 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 146 NORTH AMERICA: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 148 ASIA PACIFIC: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 149 LATIN AMERICA: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 150 MIDDLE EAST: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 151 GCC: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 152 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 153 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 154 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 155 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 156 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 157 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 158 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 159 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
- TABLE 160 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 161 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 162 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 163 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 164 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 165 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 166 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 167 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 168 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 169 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 170 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 171 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 172 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 173 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 174 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 175 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 176 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 177 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 178 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 179 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 180 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 181 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 182 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
- TABLE 183 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 184 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 185 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 186 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 187 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 188 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 189 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 190 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 191 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 192 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 193 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 194 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 195 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 196 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 197 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 198 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 199 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 200 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 201 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 202 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 203 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2022-2029 (USD MILLION)
- TABLE 204 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 205 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 206 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 207 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 208 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 209 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 210 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2029 (USD MILLION)
- TABLE 211 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 212 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 213 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 214 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 215 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 216 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 217 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 218 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 219 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 220 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 221 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 222 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 223 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 224 SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 225 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 226 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 227 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 228 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 229 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 230 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 231 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 232 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 233 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 234 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 235 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 236 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 237 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 238 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 239 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 240 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 241 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 242 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 243 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 244 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 245 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 246 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 247 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 248 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 249 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 250 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 251 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 252 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 253 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 254 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 255 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 256 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 257 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 258 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 259 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 260 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 261 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 262 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 263 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 264 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 265 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 266 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 267 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 268 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 269 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 270 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 271 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 272 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 273 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 274 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 275 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 276 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 277 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 278 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 279 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 280 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 281 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 282 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 283 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 284 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 285 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 286 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 287 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 288 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 289 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 290 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 291 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 292 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 293 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 294 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 295 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 296 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 297 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 298 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 299 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 300 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 301 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 302 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 303 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 304 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 305 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 306 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 307 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 308 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 309 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 310 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 311 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 312 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 313 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 314 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 315 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 316 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 317 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 318 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 319 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 320 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 321 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 322 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 323 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 324 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 325 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 326 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 327 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 328 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 329 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 338 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 339 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 340 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 341 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 343 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 344 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 346 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 348 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 349 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 350 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 351 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 358 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 359 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 360 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 361 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 369 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 370 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 371 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 372 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 373 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 379 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 380 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 381 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 382 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 383 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 389 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 390 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 391 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 392 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 393 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 399 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 400 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 401 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 402 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 403 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 409 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 410 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 411 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 412 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 413 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 419 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 420 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 421 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,BY TYPE, 2022–2029 (USD MILLION)
- TABLE 422 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 423 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 429 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 430 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 431 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 432 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 433 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 440 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 441 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 442 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 443 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 444 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 445 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 450 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 451 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 452 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 453 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 454 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 455 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 460 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 461 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 462 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 463 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 464 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 465 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 470 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 471 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 472 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 473 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 474 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 475 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 480 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 481 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 482 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 483 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 484 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 485 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 490 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 491 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 492 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 493 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 494 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 495 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 500 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 501 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 502 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 503 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 504 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 505 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 511 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 512 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 513 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 514 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 515 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 516 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 517 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 521 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 522 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 523 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 524 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 525 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 526 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 527 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 531 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 532 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 533 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 534 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 535 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 536 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 537 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 541 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 542 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 543 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 544 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 545 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 546 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 547 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 552 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 553 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 554 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 555 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 556 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 557 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 558 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 559 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 563 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 564 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 565 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 566 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 567 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 568 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 569 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 570 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 573 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 574 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 575 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 576 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 577 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 578 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 579 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 580 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 583 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 584 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 585 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 586 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 587 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 588 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 589 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 590 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 593 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 594 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 595 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 596 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 597 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 598 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 599 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 600 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 603 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 604 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 605 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 606 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 607 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
- TABLE 608 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
- TABLE 609 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 610 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 613 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
- TABLE 614 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 615 SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT
- TABLE 616 SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT
- TABLE 617 SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT
- TABLE 618 SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT
- TABLE 619 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 620 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 621 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024
- TABLE 622 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–JULY 2024
- TABLE 623 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
- TABLE 624 BD: COMPANY OVERVIEW
- TABLE 625 BD: PRODUCTS OFFERED
- TABLE 626 BD: PRODUCT LAUNCHES & APPROVALS
- TABLE 627 BD: DEALS
- TABLE 628 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 629 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 630 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
- TABLE 631 THERMO FISHER SCIENTIFIC INC.: DEALS
- TABLE 632 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 633 DANAHER CORPORATION: PRODUCTS OFFERED
- TABLE 634 DANAHER CORPORATION: DEALS
- TABLE 635 10X GENOMICS: COMPANY OVERVIEW
- TABLE 636 10X GENOMICS: PRODUCTS OFFERED
- TABLE 637 10X GENOMICS: PRODUCT LAUNCHES & APPROVALS
- TABLE 638 10X GENOMICS: DEALS
- TABLE 639 MERCK KGAA: COMPANY OVERVIEW
- TABLE 640 MERCK KGAA: PRODUCTS OFFERED
- TABLE 641 MERCK KGAA: DEALS
- TABLE 642 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 643 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
- TABLE 644 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS
- TABLE 645 AGILENT TECHNOLOGIES, INC.: DEALS
- TABLE 646 QIAGEN: COMPANY OVERVIEW
- TABLE 647 QIAGEN: PRODUCTS OFFERED
- TABLE 648 QIAGEN: DEALS
- TABLE 649 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 650 ILLUMINA, INC.: PRODUCTS OFFERED
- TABLE 651 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS
- TABLE 652 ILLUMINA, INC.: DEALS
- TABLE 653 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 654 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
- TABLE 655 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS
- TABLE 656 DIASORIN S.P.A.: COMPANY OVERVIEW
- TABLE 657 DIASORIN S.P.A.: PRODUCTS OFFERED
- TABLE 658 DIASORIN S.P.A.: DEALS
- TABLE 659 STANDARD BIOTOOLS: COMPANY OVERVIEW
- TABLE 660 STANDARD BIOTOOLS: PRODUCTS OFFERED
- TABLE 661 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS
- TABLE 662 STANDARD BIOTOOLS: DEALS
- TABLE 663 TECAN TRADING AG: COMPANY OVERVIEW
- TABLE 664 TECAN TRADING AG: PRODUCTS OFFERED
- TABLE 665 SARTORIUS AG: COMPANY OVERVIEW
- TABLE 666 SARTORIUS AG: PRODUCTS OFFERED
- TABLE 667 SARTORIUS AG: EXPANSIONS
- TABLE 668 CORNING INCORPORATED: COMPANY OVERVIEW
- TABLE 669 CORNING INCORPORATED: PRODUCTS OFFERED
- TABLE 670 CYTEK BIOSCIENCES: COMPANY OVERVIEW
- TABLE 671 CYTEK BIOSCIENCES: PRODUCTS OFFERED
- TABLE 672 CYTEK BIOSCIENCES: EXPANSIONS
- TABLE 673 TAKARA BIO INC.: COMPANY OVERVIEW
- TABLE 674 TAKARA BIO INC.: PRODUCTS OFFERED
- TABLE 675 BIOMÉRIEUX: COMPANY OVERVIEW
- TABLE 676 BIOMÉRIEUX: PRODUCTS OFFERED
- TABLE 677 BIOMÉRIEUX: DEALS
- TABLE 678 REVVITY: COMPANY OVERVIEW
- TABLE 679 REVVITY: PRODUCTS OFFERED
- TABLE 680 REVVITY: DEALS
- TABLE 681 BIO-TECHNE: COMPANY OVERVIEW
- TABLE 682 BIO-TECHNE: PRODUCTS OFFERED
- TABLE 683 BIO-TECHNE: DEALS
- TABLE 684 PACBIO: COMPANY OVERVIEW
- TABLE 685 PACBIO: PRODUCTS OFFERED
- TABLE 686 PACBIO: PRODUCT LAUNCHES & APPROVALS
- TABLE 687 BRUKER: COMPANY OVERVIEW
- TABLE 688 BRUKER: PRODUCTS OFFERED
- TABLE 689 BRUKER: PRODUCT LAUNCHES & APPROVALS
- TABLE 690 PROMEGA CORPORATION: COMPANY OVERVIEW
- TABLE 691 PROMEGA CORPORATION: PRODUCTS OFFERED
- TABLE 692 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
- TABLE 693 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED
- TABLE 694 SINGLERON BIOTECHNOLOGIES: BUSINESS OVERVIEW
- TABLE 695 CELL MICROSYSTEMS: BUSINESS OVERVIEW
- TABLE 696 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
- TABLE 697 RARECYTE, INC.: BUSINESS OVERVIEW
- TABLE 698 BICO: BUSINESS OVERVIEW
- TABLE 699 MENARINI GROUP: BUSINESS OVERVIEW
List of Figures
- FIGURE 1 RESEARCH DESIGN
- FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET
- FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
- FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
- FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2023
- FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
- FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS
- FIGURE 9 DATA TRIANGULATION METHODOLOGY
- FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
- FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
- FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET
- FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET
- FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2023
- FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023
- FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 1,00,000 CANCER INCIDENCES IN BOTH SEXES, 2022
- FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014-2028
- FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS FOR LAST NINE YEARS
- FIGURE 25 SINGLE-CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 29 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014-JUNE 2024
- FIGURE 30 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
- FIGURE 32 KEY BUYING CRITERIA FOR END USERS
- FIGURE 33 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2022-2029 (THOUSAND UNITS)
- FIGURE 34 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
- FIGURE 35 NIH FUNDING FOR STEM CELL RESEARCH, 2015-2025
- FIGURE 36 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
- FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2021-2023
- FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
- FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT
- FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
- FIGURE 42 EV/EBITDA OF KEY VENDORS
- FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 45 BD: COMPANY SNAPSHOT
- FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT
- FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT
- FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT
- FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- FIGURE 51 QIAGEN: COMPANY SNAPSHOT
- FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT
- FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT
- FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT
- FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT
- FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT
- FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT
- FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT
- FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT
- FIGURE 61 BIOMERIEUX: COMPANY SNAPSHOT
- FIGURE 62 REVVITY: COMPANY SNAPSHOT
- FIGURE 63 BIO-TECHNE: COMPANY SNAPSHOT
- FIGURE 64 PACBIO: COMPANY SNAPSHOT
- FIGURE 65 BRUKER: COMPANY SNAPSHOT
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.